Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04892446 · TERMINATED
Trial details
- NCT number
- NCT04892446
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-09
- Primary completion
- 2024-04-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.